There is a goal to create set of instrument for diagnosis genetically modified products. This method is based on the chain of oligonucleotides synthesized by us which is conjugated with quantum dots and which will further interact with corresponding nucleotide sequence of genetically modified product so it will be created the library of genetically modified products with their DNA signs which makes possible to determine whether the studied products contain genetically modified organisms.

Work are being carried out now on the creation of the set: conjugate "Quantum dots + streptavidin". The Institute of Molecular and Cellular Biology (IMCB SB RAS) gives us streptavidin for primary development of the Quantum dots and streptadivin conjugate

At the same time is being conducted the research on the base of IMCB SB RAS and State Scientific Center Vector aimed at the creation of conjugates with quantum dots and monoclonal/ second antibodies for development of ELISA-test systems.

Quantum dots allow to reduce considerably the speed of the instant diagnosis. The main objective is to increase sensitivity and specificity to the infectious agent. During the co-developing with the State Scientific Center Vector - rapid tests for screening -one of the widespread diseases are: flu virus, tick-borne encephalitis, causative agent of the diseases, sexually transmitted (STIs), or virus of hepatitis B or C.